As it is difficult to detect resident IPF fibroblasts in cancer patients, FoxM1 expression may be a hallmark of abnormal fibroblast phenotype and serve as a prognostic marker indicative of a higher risk of RILF. The gene discussed is FOXM1; the disease is cancer.